On October 9, Previvor Edge announced the launch of its groundbreaking clinical program designed to personalize cancer prevention and early detection for every individual. Backed by $3.3 million in an oversubscribed pre-seed round led by CoFound Partners and Max Ventures—with participation from Humbition Capital, Red Swan Ventures, and Designer Fund—the program brings together world-class expertise, a proprietary technology platform, and in-network accessibility with multiple insurance carriers.
The new offering is now open to the public, providing individuals the opportunity to join the waitlist and enabling providers to easily refer patients seeking proactive, specialized cancer prevention and detection support.
Read the full article in Healthcare IT Today here.